focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Share News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: CMC names new CFO; takeover offer for Ergomed

Mon, 04th Sep 2023 07:36

(Alliance News) - Stocks in London are expected to open on a positive note on Monday, amid an improvement in global risk sentiment.

It is likely to be a quieter trading day, given that US markets will be closed for the Labor Day public holiday.

"Last week ended on a positive note, and this week started with a solid risk appetite, as the US jobs data hinted at a finally loosening jobs market, while Chinese stocks rallied on further measures deployed by the Chinese government to support the country’s faltering property market," said Swissquote Bank's Ipek Ozkardeskaya.

In early UK company news, AstraZeneca received an approval for Calquence in China. John Wood Group and Harbour Energy signed a USD330 million strategic partnership in the UK North Sea. Ergomed agreed a GBP703 million takeover offer with a UK private equity firm.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 39.4 points, 0.5%, at 7,503.94

----------

Hang Seng: up 2.4% at 18,822.72

Nikkei 225: closed up 0.7% at 32,939.18

S&P/ASX 200: closed up 0.6% at 7,318.80

----------

DJIA: closed up 115.80 points, or 0.3%, at 34,837.71

S&P 500: closed up 0.2% at 4,515.77

Nasdaq Composite: closed little changed at 14,031.81

----------

EUR: down at USD1.0788 (USD1.0792)

GBP: up at USD1.2610 (USD1.2604)

USD: down at JPY146.17 (JPY146.21)

Gold: up at USD1,945.24 per ounce (USD1,938.09)

Oil (Brent): up at USD88.50 a barrel (USD88.00)

(changes since previous London equities close)

----------

ECONOMICS

----------

Monday's key economic events still to come:

Canada Labor Day: financial markets closed

United States Labor Day: financial markets closed

----------

Prime Minister Rishi Sunak is reportedly set to succumb to pressure from party members and overturn his de facto ban on onshore wind farms. The Telegraph reports ministers will release plans that will give councils the right to be able to build proposed wind farms if there is community support for the projects. Sunak has fought off a rebellion from within his party as ministers are said to be discussing ways to finalise the details of the amendment, particularly on how fast the government could legally scrap the ban. Plans are reportedly being written for a minister to submit a written statement to the Commons which will commit to changing the current planning rules. In October last year, Sunak pledged to keep the onshore wind farm ban in place.

----------

BROKER RATING CHANGES

----------

MS cuts Land Securities to 'equal-weight' (overweight) - price target 650 (750) pence

----------

JPMorgan cuts British Land Co to 'neutral' (overweight) - price target 410 (505) pence

----------

JPMorgan resumes Schroders with 'overweight' - target 501 pence

----------

COMPANIES - FTSE 100

----------

AstraZeneca said that acalabrutinib, or Calquence, has received approval in China for use in certain adults with chronic lymphocytic leukaemia. Calquence is a next-generation, selective Bruton's tyrosine kinase inhibitor. The approval is based on results from the Ascend global phase III trial and a phase I/II local trial, which showed 83% overall response rate in Chinese patients treated with Calquence, Astra said. "CLL is the most prevalent type of adult leukaemia across the globe and represents approximately 6.4% of B-cell non-Hodgkin lymphoma patients in China," it explained.

----------

COMPANIES - FTSE 250

----------

John Wood Group and Harbour Energy announced they have agreed on a new strategic partnership in the UK North Sea. The two companies have signed a master services agreement and associated contracts valued at around USD330 million. Under the deal, Wood will provide engineering, procurement and construction services, and operations and maintenance services for some of Harbour's offshore assets. The partnership will initially run for a five year period, with five one-year extension options.

----------

CMC Markets named Albert Soleiman as its new chief financial officer, with him taking up the role last Friday. Soleiman led the launch of CMC Invest business, after rejoining the firm in 2020. He replaces Euan Marshall, who announced he would resign to become CFO at fellow FTSE 250-listing IntegraFin back in July. Marshall remains with CMC to support an orderly transition over the next few months.

----------

OTHER COMPANIES

----------

Ergomed said it has agreed a recommended cash takeover offer from a newly incorporated company controlled and indirectly owned by funds advised by UK private equity firm Permira Advisers. The offer of 1,350 pence per share is a 28% premium to Friday's closing price of 1,052p, and values the pharmaceutical services company at GBP703.1 million. Ergomed's directors deem the offer to be "fair and reasonable", having been advised by Jefferies and Numis. They unanimously recommend that shareholders vote in favour of the offer at forthcoming court and general meetings. If all conditions pass, Ergomed expects the takeover to become effective in the first quarter of 2024.

----------

The US's Albemarle on Sunday confirmed that Australia's Liontown Resources has agreed to a cash takeover offer worth AUD6.6 billion, about USD4.3 billion. Charlotte, North Carolina-based Albemarle produces lithium and bromine, supplying these for mobility, energy, connectivity, and health applications. Liontown is a West Perth, Western Australia producer of battery minerals. Confirming an announcement by Liontown, Abermarle said it has agreed to pay AUD3.00 per Liontown share, having a submitted a best and final non-binding proposal. Liontown said its board will unanimously recommend the takeover offer once it is made binding. Abermarle said the acquisition will increase the scale of its energy storage business and the size of its battery metal resource base.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
19 Sep 2018 12:26

Ergomed Sinks To Interim Loss As Costs Rise In Spite Of Revenue Growth

LONDON (Alliance News) - Pharmaceutical services company Ergomed PLC said on Wednesday it swung to a loss for the first half of 2018 due to higher expenses and in spite of revenue the six months a

Read more
2 Jul 2018 11:02

Ergomed Appoints Stuart Jackson As Chief Financial Officer

LONDON (Alliance News) - Pharmaceutical services provider Ergomed PLC said on Monday it has appointed Stuart Jackson as chief financial officer with immediate effect.Previously, Jackson was

Read more
17 Apr 2018 18:07

Strategic Equity Takes Holding In Ergomed Across Notifiable Threshold

LONDON (Alliance News) - Ergomed PLC said Tuesday that Strategic Equity Capital PLC took its stake in the company to 5.3%.Prior to Monday's transaction it was not disclosed what holding

Read more
4 Apr 2018 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 5 April ElectrocomponentsTrading statementHSS Hire GroupFull Year Year Airlines

Read more
6 Feb 2017 09:24

Ergomed reports positive results from insomnia drug trial

(ShareCast News) - AIM-listed pharma company Ergomed on Monday reported positive top-line results from a Phase II clinical trial of Lorediplon in patients with insomnia with its co-development partner Ferrer. The company said both 5 and 10mg Lorediplon met the primary endpoint with "high statistical

Read more
29 Nov 2016 09:07

Ergomed buys drug safety and regulatory consultancy for £4m

(ShareCast News) - AIM-listed pharmaceutical Ergomed has bought Prague-based European PharmInvent Services for €4.8m (£4.1m), in order to grow its services business. The acquisition of PharmInvent, a drug safety and regulatory consultancy, will expand the company's pharmacovigilance division, PrimeV

Read more
29 Nov 2016 09:03

Ergomed Boosts PrimeVigilance Division By Purchasing PharmInvent (ALLISS)

Read more
24 Oct 2016 07:58

Ergomed Co-Development Partner Plans Name Change And Listing

Read more
14 Oct 2016 11:35

Ergomed to benefit from Zoptrex Australasia deal

(ShareCast News) - Specialised pharmaceutical services company Ergomed announced on Friday that its co-development partner, Aeterna Zentaris, has signed an additional licensing agreement for Zoptrex. The AIM-traded firm said Aeterna Zentaris signed an exclusive license agreement on Wednesday with Sp

Read more
19 Sep 2016 15:05

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
2 Sep 2016 09:27

Ergomed wins two licenses for cancer drug Zoptrex

(ShareCast News) - Pharmaceutical service provider Ergomed's development partner Aeterna Zentaris, won two licensing deals for its cancer drug Zoptrex gaining new territory in Southeast Asia and the Middle East. In July 2016 Aeterna Zentaris signed a license agreement with affiliates of Orient EuroP

Read more
20 Jul 2016 15:07

UK Shareholder Meetings Calendar - Next 7 Days

Read more
27 Jun 2016 09:41

Ergomed Opens New US Office For PrimeVigilance Business Outside Boston

Read more
13 Jun 2016 14:03

Ergomed buys two German service companies

(ShareCast News) - Ergomed, a British pharmaceutical development services company, said on Monday, it had bought two German service providers to complement and enhance its existing capabilities, and increase its presence in Germany. The company acquired Dr. Oestreich + Partner GmbH (O+P), a full ser

Read more
13 Jun 2016 06:57

Ergomed Buys Two German Service Providers To Enhance Capabilities (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.